GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 348 filers reported holding GLOBUS MED INC in Q4 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $64 | -99.9% | 862 | +18.9% | 0.00% | – |
| Q3 2022 | $43,000 | -95.0% | 725 | -95.3% | 0.00% | -100.0% |
| Q2 2022 | $861,000 | -27.3% | 15,345 | -4.5% | 0.01% | -16.7% |
| Q1 2022 | $1,185,000 | +2.6% | 16,069 | +0.4% | 0.01% | +20.0% |
| Q4 2021 | $1,155,000 | -5.8% | 16,000 | -0.1% | 0.01% | -16.7% |
| Q3 2021 | $1,226,000 | +2.1% | 16,010 | +3.3% | 0.01% | -14.3% |
| Q2 2021 | $1,201,000 | +27.2% | 15,494 | +1.2% | 0.01% | +16.7% |
| Q1 2021 | $944,000 | -3.4% | 15,311 | +2.1% | 0.01% | -14.3% |
| Q4 2020 | $977,000 | +281.6% | 14,990 | +188.9% | 0.01% | +250.0% |
| Q3 2020 | $256,000 | +884.6% | 5,189 | +868.1% | 0.00% | – |
| Q2 2020 | $26,000 | +8.3% | 536 | -3.4% | 0.00% | – |
| Q1 2020 | $24,000 | +4.3% | 555 | +24.4% | 0.00% | – |
| Q3 2019 | $23,000 | +228.6% | 446 | +154.9% | 0.00% | – |
| Q2 2019 | $7,000 | -84.8% | 175 | -81.3% | 0.00% | -100.0% |
| Q1 2019 | $46,000 | – | 938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |